Clinical trial • Phase II • Musculoskeletal
Lipiodol for Hand (digital) osteoarthritis
Phase II trial of Lipiodol for Hand (digital) osteoarthritis. 15 participants.
Overview
- Trial Therapeutic Area
- Musculoskeletal
- Trial Disease
- Hand (digital) osteoarthritis
- Trial Stage
- Phase II
- Drug Modality
- Other
Key dates
- Initial CTIS Submission Date
- 15-04-2024
- First CTIS Authorization Date
- 15-07-2024
Trial design
Phase II trial in France.
- Target Sample Size
- 15
Recruitment
- Planned Sample Size
- 15
- Recruitment Window Months
- 48
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 15
France
- Earliest CTIS Part Ii Submission Date
- 17-06-2024
- Latest Decision Or Authorization Date
- 15-07-2024
- Processing Time Days
- 28
- Number Of Sites
- 1
- Number Of Participants
- 15
Sites
- Site Name
- Centre Hospitalier Universitaire Grenoble Alpes
- Department Name
- Rhumatology
- Principal Investigator Name
- Xavier ROMAND
- Principal Investigator Email
- xromand@chu-grenoble.fr
- Contact Person Name
- Xavier ROMAND
- Contact Person Email
- xromand@chu-grenoble.fr
- Number Of Participants
- 15
Sponsor
Primary sponsor
- Full Name
- Centre Hospitalier Universitaire Grenoble Alpes
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- Lipiodol
- Modality
- Other
- Routes Of Administration
- embolisation
Related trials
Other published trials that may interest you.